WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2021 Issue has been successfully launched on 1 November 2021

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 November 2021 Issue has been Published, Kindly check it on http://www.wjahr.com/home/current_issues

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

EVALUATING THE RESPONSE TO COMBINATION THERAPY WITH NEBULIZED AMIKACIN, IV AMIKACIN AND MEROPENEM IN PATIENTS WITH VENTILATOR-ACQUIRED-PNEUMONIA WITH RESISTANT SERRATIA TRACHEAL CULTURES IN ICU OF VALI-E-ASR HOSPITAL IN ZANJAN

Mehdi Azimi, Dr. Seyede Sahar Babaali* and Amirhossein Moghtader Mojdehi

ABSTRACT

Background: There have been reports of increased rates of multi-drug resistant VAP in the ICU of Zanjan Vali-e-Asr hospital. Suggesting an appropriate therapeutic regimen is of paramount importance, which is the main goal of this study. Method: This non-randomized uncontrolled semi experimental study was carried out with a total number of 45 patients who were selected from ICU of Zanjan Vali-e-Asr hospital. All patients were diagnosed with Serattia-positive multi-drug resistant VAP and treated with the suggested therapeutic regimen. The effectiveness of the regimen was evaluated through the CPIS before and after the treatment. Thereafter, the results were analyzed by SPSS and STATA software. Results: Our data indicate significant changes in body temperature with p value=0.004 (from 37.4±0.6 on the 1st day to 37±0.3 on the 15th day), pulse rate with p value=0.003(from 90.8±16.1 on the 1st day to 83.7±9.1 on the 15th day), systolic blood pressure with p value=0.009 (from 108.8±10.5 on the 1st day to 107.1±8.8 on the 15th day) and creatinine level with p value=0.005(from 1.4±1.3 on the 1st day to 1±0.6 on the 15th day). Although not statistically significant, radiologic changes and the pulmonary secretion both followed an overall improving pattern. The total cure rates on day 7 and day 15 were not statistically significant. Conclusion: Our study reports a positive response to our recommended therapeutic regimen in patients with VAP. Our findings also indicate that the antibiotic preference is not dependent on early or late VAP; especially in complicated cases such as patients admitted to ICU. We highly recommend a similar study conducted with the control group.

[Full Text Article]